INNOVATIVE MEDICINES INITIATIVE 2 STARTS WORK
July 5th, 2014
THE EUROPEAN Union’s (EU) Innovative Medicines Initiative (IMI) second phase has now started operations, launching a call for proposed research projects that could receive funding from an initial budget of EUR24.63 million. The ambitious private-public research scheme will spend EUR3.3 billion until 2024, with the “goal of fast-tracking the development of the next generation of medicines, especially in areas of unmet need,” said an IMI note. It is a partnership between the European Union (EU) and the European Federation of Pharmaceutical Industries and ...
Full access to this article can be arranged with permission from the client that first ordered it. Please contact us to request access. Entries are uploaded to our archive at least one year after being published by a client – free access is restricted to International News Services journalists for background research only. The article date indicates when copy was filed to a client, not when posted to this archive. Upon client requests, International News Services will remove such articles from the archive or not upload them in the first place. They are included to demonstrate the breadth of topics undertaken by the agency and also to help promote clients’ coverage.